KDM6A mutations are enriched in cases of core-binding factor AML initiated by the RUNX1-RUNX1T1 fusion gene, where 6–7% of these patients also have mutations in KDM6A [21, 22]. This evidence concerns the gene KDM6A and acute myeloid leukemia.